Table 4. Hospitalization, Mortality, and Resource Use over a 1-Year Period for HIV Patients Who Developed PCP

You Are Here: AHRQ Home > Research Findings > Research in Action > Prescription Drug Therapies > Table 4

Prescription Drug Therapies

Table 4. Hospitalization, Mortality, and Resource Use over a 1-Year Period for HIV Patients Who Developed PCP

Item		Taking preventive drugs
Item		Yes	No
Number of patients:	Hospitalized	11	54
	Had an ICU stay	0	10
	Died	0	12
Total hospital days		137	800
ICU days		0	202
Total charges		$95,932	$753,608

Note: ICU—intensive care unit. PCP—Pneumocystis carinii pneumonia.

Source: Gallant JE, McAvinue SM, Moore RD, et al. The impact of prophylaxis on outcome and resource utilization in Pneumocystis carinii pneumonia. Chest 1995; 107:1018-23.

Return to Document